Geode Capital Management
CMPX icon

Geode Capital Management’s Compass Therapeutics CMPX Stock Holding History

Geode Capital Management’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.36M Buy
3,815,189
+249,419
+7% +$736K ﹤0.01% 2643
2026
Q1 		$18.9M Buy
3,565,770
+63,244
+2% +$365K ﹤0.01% 2024
2025
Q4 		$18.8M Buy
3,502,526
+558,057
+19% +$2.58M ﹤0.01% 2041
2025
Q3 		$10.3M Buy
2,944,469
+625,337
+27% +$1.98M ﹤0.01% 2398
2025
Q2 		$6.03M Sell
2,319,132
-45,764
-2% -$94.4K ﹤0.01% 2637
2025
Q1 		$4.49M Buy
2,364,896
+30,725
+1% +$81.7K ﹤0.01% 2709
2024
Q4 		$3.39M Buy
2,334,171
+24,393
+1% +$40.5K ﹤0.01% 2932
2024
Q3 		$4.25M Buy
2,309,778
+19,095
+0.8% +$23.8K ﹤0.01% 2844
2024
Q2 		$2.29M Buy
2,290,683
+215,348
+10% +$315K ﹤0.01% 3088
2024
Q1 		$4.11M Buy
2,075,335
+83,307
+4% +$144K ﹤0.01% 2803
2023
Q4 		$3.11M Buy
1,992,028
+99,707
+5% +$173K ﹤0.01% 2934
2023
Q3 		$3.73M Buy
1,892,321
+84,114
+5% +$208K ﹤0.01% 2791
2023
Q2 		$5.75M Buy
1,808,207
+924,644
+105% +$2.9M ﹤0.01% 2611
2023
Q1 		$2.89M Buy
883,563
+93,315
+12% +$366K ﹤0.01% 2880
2022
Q4 		$3.97M Buy
790,248
+188,924
+31% +$754K ﹤0.01% 2772
2022
Q3 		$1.37M Buy
601,324
+576,467
+2,319% +$1.6M ﹤0.01% 3235
2022
Q2 		$65K Hold
24,857
– – ﹤0.01% 4713
2022
Q1 		$34K Buy
+24,857
New +$51.4K ﹤0.01% 4878

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management's CMPX Position: Q2 2026 in Review

Geode Capital Management increased its Compass Therapeutics (CMPX) stake by 7% in Q2 2026, buying an estimated $736K and bringing the position to 3,815,189 shares worth $8.36M. The position accounts for ﹤0.01% of the portfolio, ranked #2643.

Geode Capital Management first reported a position in CMPX in Q1 2022 and has held it in 18 quarters since. The position peaked at $18.9M in Q1 2026. 216 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • Geode Capital Management held 3,815,189 shares of Compass Therapeutics worth $8.36M as of Q2 2026.
  • Geode Capital Management bought 249,419 Compass Therapeutics shares in Q2 2026, an estimated $736K.
  • Compass Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2643 holding.
  • Geode Capital Management first reported a position in Compass Therapeutics in Q1 2022 and has held it in 18 quarters since.
  • Geode Capital Management's Compass Therapeutics position peaked at $18.9M in Q1 2026.
  • 216 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.